Trial intelligence / Profile preview

LEEDS Prisons Project detoxification trial

2005-001195-13Phase 4Completed

Sponsor
University of Leeds
Start
Jul 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in opioid use disorder (OUD) comparing Buprenorphine (Subutex) detoxification with Methadone detoxification (2 arms). Primary endpoint: Abstinence at completion of 21-day detoxification regimen. Started Jul 2005; status: completed.

02

Drugs

buprenorphinemethadone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on 2005-001195-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001195-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call